{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T04:47:56Z","timestamp":1785041276504,"version":"3.55.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T00:00:00Z","timestamp":1553904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00223-019-00538-9","type":"journal-article","created":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T07:02:41Z","timestamp":1553929361000},"page":"193-204","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Pharmacological Inhibition of NF\u03baB Reduces Prostate Cancer Related Osteoclastogenesis In Vitro and Osteolysis Ex Vivo"],"prefix":"10.1007","volume":"105","author":[{"given":"Silvia","family":"Marino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan T.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovana","family":"Carrasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Logan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aymen I.","family":"Idris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,30]]},"reference":[{"key":"538_CR1","first-page":"54841","volume":"279","author":"ML Chaisson","year":"2004","unstructured":"Chaisson ML, Branstetter DG, Derry JM, Armstrong AP, Tometsko ME, Takeda K, Akira S, Dougall WC (2004) Osteoclast differentiation is impaired in the absence of inhibitor of kappa B kinase alpha. JBiolChem 279:54841\u201354848","journal-title":"JBiolChem"},{"key":"538_CR2","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1084\/jem.20042081","volume":"201","author":"MG Ruocco","year":"2005","unstructured":"Ruocco MG, Maeda S, Park JM, Lawrence T, Hsu LC, Cao Y, Schett G, Wagner EF, Karin M (2005) I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss. J ExpMed 201:1677\u20131687","journal-title":"J ExpMed"},{"key":"538_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1210\/en.2008-0998","volume":"150","author":"AI Idris","year":"2009","unstructured":"Idris AI, Greig IR, Bassonga-Landao E, Ralston SH, t Hof RJ (2009) Identification of novel biphenyl carboxylic acid derivatives as novel antiresorptive agents that do not impair parathyroid hormone-induced bone formation. Endocrinology 150:5\u201313","journal-title":"Endocrinology"},{"key":"538_CR4","doi-asserted-by":"publisher","first-page":"4545","DOI":"10.1096\/fj.10-164095","volume":"24","author":"AI Idris","year":"2010","unstructured":"Idris AI, Krishnan M, Simic P, Landao-Bassonga E, Mollat P, Vukicevic S, Ralston SH (2010) Small molecule inhibitors of I{kappa}B kinase signaling inhibit osteoclast formation in vitro and prevent ovariectomy-induced bone loss in vivo. FASEB J 24:4545\u20134555","journal-title":"FASEB J"},{"key":"538_CR5","first-page":"525","volume":"87","author":"AI Idris","year":"2010","unstructured":"Idris AI, Coste E, Greig IR, Ralston SH, van\u2019t Hof RJ (2010) The biphenyl-carboxylate derivative ABD328 is a novel orally active antiresorptive agent. CalcifTissue Int 87:525\u2013532","journal-title":"CalcifTissue Int"},{"key":"538_CR6","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/jbmr.4","volume":"25","author":"JE Otero","year":"2010","unstructured":"Otero JE, Dai S, Alhawagri MA, Darwech I, Abu-Amer Y (2010) IKKbeta activation is sufficient for RANK-independent osteoclast differentiation and osteolysis. JBone MinerRes 25:1282\u20131294","journal-title":"JBone MinerRes"},{"key":"538_CR7","first-page":"62","volume":"13","author":"BK Park","year":"2007","unstructured":"Park BK, Zhang H, Zeng Q, Dai J, Keller ET, Giordano T, Gu K, Shah V, Pei L, Zarbo RJ, McCauley L, Shi S, Chen S, Wang CY (2007) NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. NatMed 13:62\u201369","journal-title":"NatMed"},{"key":"538_CR8","first-page":"682","volume":"15","author":"J Chang","year":"2009","unstructured":"Chang J, Wang Z, Tang E, Fan Z, McCauley L, Franceschi R, Guan K, Krebsbach PH, Wang CY (2009) Inhibition of osteoblastic bone formation by nuclear factor-kappaB. NatMed 15:682\u2013689","journal-title":"NatMed"},{"key":"538_CR9","doi-asserted-by":"publisher","first-page":"4626","DOI":"10.1210\/en.2010-0399","volume":"151","author":"N Alles","year":"2010","unstructured":"Alles N, Soysa NS, Hayashi J, Khan M, Shimoda A, Shimokawa H, Ritzeler O, Akiyoshi K, Aoki K, Ohya K (2010) Suppression of NF-kappaB increases bone formation and ameliorates osteopenia in ovariectomized mice. Endocrinology 151:4626\u20134634","journal-title":"Endocrinology"},{"key":"538_CR10","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/cr.2008.30","volume":"18","author":"M Karin","year":"2008","unstructured":"Karin M (2008) The IkappaB kinase\u2014a bridge between inflammation and cancer. Cell Res 18:334\u2013342","journal-title":"Cell Res"},{"key":"538_CR11","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1093\/emboj\/20.6.1271","volume":"20","author":"N Kobayashi","year":"2001","unstructured":"Kobayashi N, Kadono Y, Naito A, Matsumoto K, Yamamoto T, Tanaka S, Inoue J (2001) Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis. EMBO J 20:1271\u20131280","journal-title":"EMBO J"},{"key":"538_CR12","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1101\/gad.13.8.1015","volume":"13","author":"MA Lomaga","year":"1999","unstructured":"Lomaga MA, Yeh WC, Sarosi I, Duncan GS, Furlonger C, Ho A, Morony S, Capparelli C, Van G, Kaufman S, van der HA, Itie, Wakeham A, Khoo A, Sasaki W, Cao T, Penninger Z, Paige JM, Lacey CJ, Dunstan DL, Boyle CR, Goeddel WJ, Mak DV TW (1999) TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev 13:1015\u20131024","journal-title":"Genes Dev"},{"key":"538_CR13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1046\/j.1365-2443.1999.00265.x","volume":"4","author":"A Naito","year":"1999","unstructured":"Naito A, Azuma S, Tanaka S, Miyazaki T, Takaki S, Takatsu K, Nakao K, Nakamura K, Katsuki M, Yamamoto T, Inoue J (1999) Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells 4:353\u2013362","journal-title":"Genes Cells"},{"key":"538_CR14","doi-asserted-by":"publisher","first-page":"37409","DOI":"10.1074\/jbc.M307416200","volume":"278","author":"B Ciani","year":"2003","unstructured":"Ciani B, Layfield R, Cavey JR, Sheppard PW, Searle MS (2003) Structure of the UBA domain of p62 (SQSTM1) and implications for mutations which cause Paget\u2019s disease of bone. J Biol Chem 278:37409\u201337412","journal-title":"J Biol Chem"},{"key":"538_CR15","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/ni.2065","volume":"12","author":"A Oeckinghaus","year":"2011","unstructured":"Oeckinghaus A, Hayden MS, Ghosh S (2011) Crosstalk in NF-kappaB signaling pathways. Nat Immunol 12:695\u2013708","journal-title":"Nat Immunol"},{"key":"538_CR16","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/jbmr.2108","volume":"29","author":"Z Yao","year":"2014","unstructured":"Yao Z, Li Y, Yin X, Dong Y, Xing L, Boyce BF (2014) NF-kappaB RelB negatively regulates osteoblast differentiation and bone formation. J Bone Miner Res 29:866\u2013877","journal-title":"J Bone Miner Res"},{"key":"538_CR17","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1101\/gad.1228704","volume":"18","author":"MS Hayden","year":"2004","unstructured":"Hayden MS, Ghosh S (2004) Signaling to NF-kappaB. Genes Dev 18:2195\u20132224","journal-title":"Genes Dev"},{"key":"538_CR18","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nm.1954","volume":"15","author":"J Chang","year":"2009","unstructured":"Chang J, Wang Z, Tang E, Fan Z, McCauley L, Franceschi R, Guan K, Krebsbach PH, Wang CY (2009) Inhibition of osteoblastic bone formation by nuclear factor-kappaB. Nat Med 15:682\u2013689","journal-title":"Nat Med"},{"key":"538_CR19","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1749-6632.2009.05315.x","volume":"1192","author":"BF Boyce","year":"2010","unstructured":"Boyce BF, Yao Z, Xing L (2010) Functions of nuclear factor kappaB in bone. Ann N Y Acad Sci 1192:367\u2013375","journal-title":"Ann N Y Acad Sci"},{"key":"538_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3803\/EnM.2015.30.1.35","volume":"30","author":"BF Boyce","year":"2015","unstructured":"Boyce BF, Xiu Y, Li J, Xing L, Yao Z (2015) NF-\u03baB-mediated regulation of osteoclastogenesis. Endocrinol Metab (Seoul) 30:35\u201344","journal-title":"Endocrinol Metab (Seoul)"},{"key":"538_CR21","doi-asserted-by":"crossref","unstructured":"Amarasekara DS, Yun H, Kim S, Lee N, Kim H, Rho J (2018) Regulation of osteoclast differentiation by cytokine networks. Immune Netw 18","DOI":"10.4110\/in.2018.18.e8"},{"key":"538_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","volume":"27","author":"RE Coleman","year":"2001","unstructured":"Coleman RE (2001) Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer TreatRev 27:165\u2013176","journal-title":"Cancer TreatRev"},{"key":"538_CR23","first-page":"584","volume":"2","author":"GR Mundy","year":"2002","unstructured":"Mundy GR (2002) Metastasis to bone: causes, consequences and therapeutic opportunities. NatRevCancer 2:584\u2013593","journal-title":"NatRevCancer"},{"key":"538_CR24","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1056\/NEJMra030831","volume":"350","author":"GD Roodman","year":"2004","unstructured":"Roodman GD (2004) Mechanisms of bone metastasis. NEnglJMed 350:1655\u20131664","journal-title":"NEnglJMed"},{"key":"538_CR25","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.juro.2008.04.140","volume":"180","author":"MP Roudier","year":"2008","unstructured":"Roudier MP, Morrissey C, True LD, Higano CS, Vessella RL, Ott SM (2008) Histopathological assessment of prostate cancer bone osteoblastic metastases. J Urol 180:1154\u20131160","journal-title":"J Urol"},{"key":"538_CR26","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1464-410X.2006.06670.x","volume":"99","author":"I Vela","year":"2007","unstructured":"Vela I, Gregory L, Gardiner EM, Clements JA, Nicol DL (2007) Bone and prostate cancer cell interactions in metastatic prostate cancer. BJU Int 99:735\u2013742","journal-title":"BJU Int"},{"key":"538_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrc1528","volume":"5","author":"CJ Logothetis","year":"2005","unstructured":"Logothetis CJ, Lin SH (2005) Osteoblasts in prostate cancer metastasis to bone. Nat Rev Cancer 5:21\u201328","journal-title":"Nat Rev Cancer"},{"key":"538_CR28","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1002\/1097-0142(20000615)88:12+<2892::AID-CNCR2>3.0.CO;2-Y","volume":"88","author":"TA Guise","year":"2000","unstructured":"Guise TA (2000) Molecular mechanisms of osteolytic bone metastases. Cancer 88:2892\u20132898","journal-title":"Cancer"},{"key":"538_CR29","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/pros.20678","volume":"68","author":"AP Armstrong","year":"2008","unstructured":"Armstrong AP, Miller RE, Jones JC, Zhang J, Keller ET, Dougall WC (2008) RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes. Prostate 68:92\u2013104","journal-title":"Prostate"},{"key":"538_CR30","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s10555-006-9023-1","volume":"25","author":"VA Siclari","year":"2006","unstructured":"Siclari VA, Guise TA, Chirgwin JM (2006) Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases. Cancer Metastasis Rev 25:621\u2013633","journal-title":"Cancer Metastasis Rev"},{"key":"538_CR31","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/path.1199","volume":"198","author":"S Kitazawa","year":"2002","unstructured":"Kitazawa S, Kitazawa R (2002) RANK ligand is a prerequisite for cancer-associated osteolytic lesions. JPathol 198:228\u2013236","journal-title":"JPathol"},{"key":"538_CR32","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1158\/1535-7163.MCT-08-0046","volume":"7","author":"RE Miller","year":"2008","unstructured":"Miller RE, Roudier M, Jones J, Armstrong A, Canon J, Dougall WC (2008) RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis. Mol Cancer Ther 7:2160\u20132169","journal-title":"Mol Cancer Ther"},{"key":"538_CR33","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/nature05656","volume":"446","author":"JL Luo","year":"2007","unstructured":"Luo JL, Tan W, Ricono JM, Korchynskyi O, Zhang M, Gonias SL, Cheresh DA, Karin M (2007) Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin. Nature 446:690\u2013694","journal-title":"Nature"},{"key":"538_CR34","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/sj.onc.1209066","volume":"25","author":"A Yemelyanov","year":"2006","unstructured":"Yemelyanov A, Gasparian A, Lindholm P, Dang L, Pierce JW, Kisseljov F, Karseladze A, Budunova I (2006) Effects of IKK inhibitor PS1145 on NF-kappaB function, proliferation, apoptosis and invasion activity in prostate carcinoma cells. Oncogene 25:387\u2013398","journal-title":"Oncogene"},{"key":"538_CR35","doi-asserted-by":"publisher","first-page":"6762","DOI":"10.1158\/0008-5472.CAN-08-0107","volume":"68","author":"RJ Jin","year":"2008","unstructured":"Jin RJ, Lho Y, Connelly L, Wang Y, Yu X, Jean LS, Case TC, Ellwood-Yen K, Sawyers CL, Bhowmick NA, Blackwell TS, Yull FE, Matusik RJ (2008) The NF-\u03baB pathway controls progression of prostate cancer to androgen independent growth. Cancer Res 68:6762\u20136769","journal-title":"Cancer Res"},{"key":"538_CR36","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1046\/j.1464-410X.2003.04104.x","volume":"91","author":"L Lessard","year":"2003","unstructured":"Lessard L, Mes-Masson AM, Lamarre L, Wall L, Lattouf JB, Saad F (2003) NF-kappa B nuclear localization and its prognostic significance in prostate cancer. BJU Int 91:417\u2013420","journal-title":"BJU Int"},{"key":"538_CR37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/01.blo.0000093048.96273.aa","volume":"415","author":"VB Andela","year":"2003","unstructured":"Andela VB, Gordon AH, Zotalis G, Rosier RN, Goater JJ, Lewis GD, Schwarz EM, Puzas JE, O\u2019Keefe RJ (2003) NFkappaB: a pivotal transcription factor in prostate cancer metastasis to bone. Clin Orthop Relat Res 415:75\u201385","journal-title":"Clin Orthop Relat Res"},{"key":"538_CR38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1242\/jcs.115.1.141","volume":"115","author":"AV Gasparian","year":"2002","unstructured":"Gasparian AV, Yao YJ, Kowalczyk D, Lyakh LA, Karseladze A, Slaga TJ, Budunova IV (2002) The role of IKK in constitutive activation of NF-kappaB transcription factor in prostate carcinoma cells. J Cell Sci 115:141\u2013151","journal-title":"J Cell Sci"},{"key":"538_CR39","doi-asserted-by":"publisher","first-page":"14487","DOI":"10.18632\/oncotarget.11629","volume":"8","author":"B Peant","year":"2017","unstructured":"Peant B, Gilbert S, Le Page C, Poisson A, L\u2019Ecuyer E, Boudhraa Z, Bienz MN, Delvoye N, Saad F, Mes-Masson AM (2017) IkappaB-Kinase-epsilon (IKKepsilon) over-expression promotes the growth of prostate cancer through the C\/EBP-beta dependent activation of IL-6 gene expression. Oncotarget 8:14487\u201314501","journal-title":"Oncotarget"},{"key":"538_CR40","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/pros.20912","volume":"69","author":"B Peant","year":"2009","unstructured":"Peant B, Diallo JS, Dufour F, Le Page C, Delvoye N, Saad F, Mes-Masson AM (2009) Over-expression of IkappaB-kinase-epsilon (IKKepsilon\/IKKi) induces secretion of inflammatory cytokines in prostate cancer cell lines. Prostate 69:706\u2013718","journal-title":"Prostate"},{"key":"538_CR41","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/pros.10335","volume":"58","author":"HA Ismail","year":"2004","unstructured":"Ismail HA, Lessard L, Mes-Masson AM, Saad F (2004) Expression of NF-kappaB in prostate cancer lymph node metastases. Prostate 58:308\u2013313","journal-title":"Prostate"},{"key":"538_CR42","doi-asserted-by":"publisher","first-page":"8460","DOI":"10.1158\/1078-0432.CCR-04-0764","volume":"10","author":"V Fradet","year":"2004","unstructured":"Fradet V, Lessard L, Begin LR, Karakiewicz P, Masson AM, Saad F (2004) Nuclear factor-kappaB nuclear localization is predictive of biochemical recurrence in patients with positive margin prostate cancer. Clin Cancer Res 10:8460\u20138464","journal-title":"Clin Cancer Res"},{"key":"538_CR43","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nature09707","volume":"470","author":"W Tan","year":"2011","unstructured":"Tan W, Zhang W, Strasner A, Grivennikov S, Cheng JQ, Hoffman RM, Karin M (2011) Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. Nature 470:548\u2013553","journal-title":"Nature"},{"key":"538_CR44","first-page":"759","volume":"8","author":"BH Kwok","year":"2001","unstructured":"Kwok BH, Koh B, Ndubuisi MI, Elofsson M, Crews CM (2001) The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase. ChemBiol 8:759\u2013766","journal-title":"ChemBiol"},{"key":"538_CR45","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.4049\/jimmunol.163.10.5617","volume":"163","author":"SP Hehner","year":"1999","unstructured":"Hehner SP, Hofmann TG, Droge W, Schmitz ML (1999) The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex. J Immunol 163:5617\u20135623","journal-title":"J Immunol"},{"key":"538_CR46","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1158\/1535-7163.MCT-09-0133","volume":"8","author":"AI Idris","year":"2009","unstructured":"Idris AI, Libouban H, Nyangoga H, Landao-Bassonga E, Chappard D, Ralston SH (2009) Pharmacologic inhibitors of IkappaB kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolytic bone metastasis in vivo. Mol Cancer Ther 8:2339\u20132347","journal-title":"Mol Cancer Ther"},{"key":"538_CR47","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.canlet.2017.09.034","volume":"410","author":"S Marino","year":"2017","unstructured":"Marino S, Bishop RT, Logan JG, Mollat P, Idris AI (2017) Pharmacological evidence for the bone-autonomous contribution of the NFkappaB\/beta-catenin axis to breast cancer related osteolysis. Cancer Lett 410:180\u2013190","journal-title":"Cancer Lett"},{"key":"538_CR48","doi-asserted-by":"publisher","first-page":"16134","DOI":"10.18632\/oncotarget.24743","volume":"9","author":"S Marino","year":"2018","unstructured":"Marino S, Bishop RT, Capulli M, Sophocleous A, Logan JG, Mollat P, Mognetti B, Ventura L, Sims AH, Rucci N, Ralston SH, Idris AI (2018) Regulation of breast cancer induced bone disease by cancer-specific IKK\u03b2. Oncotarget 9:16134\u201316148","journal-title":"Oncotarget"},{"key":"538_CR49","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s00223-018-0406-4","volume":"103","author":"S Marino","year":"2018","unstructured":"Marino S, Bishop RT, Mollat P, Idris AI (2018) Pharmacological inhibition of the skeletal IKKbeta reduces breast cancer-induced osteolysis. Calcif Tissue Int 103:206\u2013216","journal-title":"Calcif Tissue Int"},{"key":"538_CR50","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0022-1759(01)00347-7","volume":"252","author":"H Gloeckner","year":"2001","unstructured":"Gloeckner H, Jonuleit T, Lemke HD (2001) Monitoring of cell viability and cell growth in a hollow-fiber bioreactor by use of the dye Alamar Blue. J Immunol Methods 252:131\u2013138","journal-title":"J Immunol Methods"},{"key":"538_CR51","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1177\/1087057105279635","volume":"10","author":"JM Atienza","year":"2005","unstructured":"Atienza JM, Zhu J, Wang X, Xu X, Abassi Y (2005) Dynamic monitoring of cell adhesion and spreading on microelectronic sensor arrays. J Biomol Screen 10:795\u2013805","journal-title":"J Biomol Screen"},{"key":"538_CR52","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/bonekey.2014.59","volume":"3","author":"GM Campbell","year":"2014","unstructured":"Campbell GM, Sophocleous A (2014) Quantitative analysis of bone and soft tissue by micro-computed tomography: applications to ex vivo and in vivo studies. BoneKEy reports 3:564","journal-title":"BoneKEy reports"},{"key":"538_CR53","doi-asserted-by":"crossref","unstructured":"Marino S, Logan J, Mellis G, Capulli D M (2014) Generation and culture of osteoclasts. BoneKEy Rep 3","DOI":"10.1038\/bonekey.2014.65"},{"key":"538_CR54","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/bonekey.2014.80","volume":"3","author":"SE Taylor","year":"2014","unstructured":"Taylor SE, Shah M, Orriss IR (2014) Generation of rodent and human osteoblasts. Bonekey Rep 3:585","journal-title":"Bonekey Rep"},{"key":"538_CR55","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.bone.2004.03.036","volume":"35","author":"AI Idris","year":"2004","unstructured":"Idris AI, Del SP, Ralston SH, van\u2019t Hof RJ (2004) The flurbiprofen derivatives HCT1026 and HCT1027 inhibit bone resorption by a mechanism independent of COX inhibition and nitric oxide production. Bone 35:636\u2013643","journal-title":"Bone"},{"key":"538_CR56","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/15216540500137669","volume":"57","author":"X Feng","year":"2005","unstructured":"Feng X (2005) RANKing intracellular signaling in osteoclasts. IUBMBLife 57:389\u2013395","journal-title":"IUBMBLife"},{"key":"538_CR57","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","volume":"12","author":"T Wada","year":"2006","unstructured":"Wada T, Nakashima T, Hiroshi N, Penninger JM (2006) RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 12:17\u201325","journal-title":"Trends Mol Med"},{"key":"538_CR58","doi-asserted-by":"publisher","unstructured":"de Gorter DJ, ten Dijke, P (2013) Signal transduction cascades controlling osteoblast differentiation. In: Rosen CJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism. https:\/\/doi.org\/10.1002\/9781118453926.ch2","DOI":"10.1002\/9781118453926.ch2"},{"key":"538_CR59","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.eururo.2015.06.039","volume":"68","author":"BA Gartrell","year":"2015","unstructured":"Gartrell BA, Coleman R, Efstathiou E, Fizazi K, Logothetis CJ, Smith MR, Sonpavde G, Sartor O, Saad F (2015) Metastatic prostate cancer and the bone: significance and therapeutic options. Eur Urol 68:850\u2013858","journal-title":"Eur Urol"},{"key":"538_CR60","first-page":"1619","volume":"62","author":"I Holen","year":"2002","unstructured":"Holen I, Croucher PI, Hamdy FC, Eaton CL (2002) Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells. Cancer Res 62:1619\u20131623","journal-title":"Cancer Res"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-019-00538-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-019-00538-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-019-00538-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T04:50:20Z","timestamp":1694753420000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-019-00538-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,30]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["538"],"URL":"https:\/\/doi.org\/10.1007\/s00223-019-00538-9","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,30]]},"assertion":[{"value":"23 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Silvia Marino, Ryan T. Bishop, Giovana Carrasco, John G. Logan, Boya Li, and Aymen I. Idris declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}